-
公开(公告)号:EP3981769A1
公开(公告)日:2022-04-13
申请号:EP20817895.4
申请日:2020-06-05
发明人: QIAN, Wenyuan , WEI, Changqing , HU, Guoping , LI, Jian , CHEN, Shuhui
IPC分类号: C07D487/04 , C07D519/00 , A61P29/00 , A61K31/519
摘要: The present invention relates to a pyrrolopyrimidine compound used as a JAK inhibitor, and the use thereof in the preparation of a drug for treating a JAK1- and/or JAK2-associated disease, and in specifically relates to a compound represented by formula (I), an isomer thereof or a pharmaceutically acceptable salt thereof.
-
公开(公告)号:EP3640250A1
公开(公告)日:2020-04-22
申请号:EP18818915.3
申请日:2018-06-13
发明人: LIAO, Yonggang , LIU, Chaonan , WEI, Changqing , WU, Hao , CHEN, Shuhui
IPC分类号: C07D417/14 , A61K31/501 , A61K31/4439 , A61P35/00
摘要: A compound as a GLS1 inhibitor as represented by formula (I) or a pharmaceutically acceptable salt thereof.
-
公开(公告)号:EP4067351A1
公开(公告)日:2022-10-05
申请号:EP20894671.5
申请日:2020-11-27
发明人: LIAO, Yonggang , QIAN, Wenyuan , WEI, Changqing , XIAO, Yao , XI, Zhengying , ZHANG, Chen , LI, Jian , CHEN, Shuhui
IPC分类号: C07D403/12 , C07D403/14 , C07D401/14 , A61K31/4985 , A61K31/415 , A61P35/00
摘要: Disclosed are a diazaindole derivative as shown in formula I and the use thereof in the preparation of a drug for treating Chk1-related diseases.
-
公开(公告)号:EP4166541A1
公开(公告)日:2023-04-19
申请号:EP21820982.3
申请日:2021-06-07
发明人: QIAN, Wenyuan , LIAO, Yonggang , WEI, Changqing , XI, Zhengying , XIAO, Yao , CHEN, Shuhui
IPC分类号: C07D213/71 , C07D307/64 , C07D231/18 , C07D333/34 , C07D263/46 , C07D277/36 , A61K31/175
摘要: Disclosed in the present invention is a series of dimethylsulfoximine derivatives, and specifically disclosed are a compound represented by formula (II) and a pharmaceutically acceptable salt thereof.
-
公开(公告)号:EP3868758A1
公开(公告)日:2021-08-25
申请号:EP19874268.6
申请日:2019-10-15
发明人: LIAO, Yonggang , LIN, Jun , LIU, Chaonan , WEI, Changqing , QIAN, Wenyuan , ZHANG, Chen , GONG, Zhen , LI, Jian , CHEN, Shuhui
IPC分类号: C07D417/14 , A61K31/433 , A61P35/00
摘要: Disclosed is to a thiadiazole derivative and the uses thereof in preparing a drug for treating GLS1-associated diseases. Specifically disclosed is a derivative compound of formula (I), a tautomer thereof or a pharmaceutically acceptable composition thereof.
-
-
-
-